The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
Microsoft has partnered with the Ministry of Skill Development & Entrepreneurship (MSDE), and Capacity Building Commission (CBC) to empower India's civil servants with future-ready skills.